ILA — Island Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$96.17m
- AU$83.30m
- AU$0.28m
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic
Brief: Island Pharmaceuticals Says Galidesivir Approved For Treatment Use In Ebola Epidemic
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals Says FDA Grants Orphan Designation For Galidesivir In Marburg
Australia's Island Pharmaceuticals rises on agreement extension with US Army
Brief: Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir Commenced
Australia's Island Pharmaceuticals rises on US government collaboration
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals Reports Placement Of A$9 Million At A$0.35 Each
Brief: Island Pharmaceuticals Seeks Trading Halt
Australia's Island Pharmaceuticals rises on US patent for Ebola drug
Brief: Island Pharmaceuticals Says US Patent Granted For Galidesivir In Filoviridae Viruses
Brief: Island Pharmaceuticals Says FDA Advises It Requires Additional Time To Finalise Response To Co's Submission
Australia's Island Pharmaceuticals hits record high on regulatory progress with FDA
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals Says FDA Grants Co Type C Meeting Under Galidesivir's Open IND Application